The Hospital Clínic de Barcelona-IDIBAPS has developed a new CAR-T treatment for multiple myeloma, the second most common blood cancer, with encouraging results: “all patients improve, 75% of them maintain the response and not they have disease progression at 12 months, and 60% have complete remission without residual disease “, says Dr. Fernández de Larrea, [...]
Sorry, this entry is only available in European Spanish.
Sorry, this entry is only available in European Spanish.
Sorry, this entry is only available in European Spanish.
Sorry, this entry is only available in European Spanish.
Sorry, this entry is only available in European Spanish.
Sorry, this entry is only available in European Spanish.
Sorry, this entry is only available in European Spanish.
Sorry, this entry is only available in European Spanish.